Connecting products and people
IEUM Bionics · Investor overview
One company. Two capital pathways.
IEUM Bionics is a founder-led technology venture preparing for incorporation in Germany. A shared philosophy of connection and Health Avatar unite distinct development scopes and staged financing plans.
Distinct scopes and capital plans
Documented invention candidates
01
Development and capital
A clear purpose for each pathway.
Connected wearables. Health Avatar.
An initial development plan connecting a wearable family through Health Avatar. The financing plan supports staged device engineering, system integration, and a bounded evaluation of value for adult users.
Living interfaces and bionics.
A long-term research and development program that includes the NEXUS-CGM product family. Its separate capital pathway supports staged examination of technical feasibility and system evidence.
Investment discussions use materials that align the scope, objectives, and budget of the relevant pathway.
NEXUS-CGM
Three roles in one planned product family.
Implantable sensing
Continuous glucose measurement inside the body is the intended application.
External Companion
Dedicated non-invasive observations add body context for staged evaluation.
Health Avatar
The shared user interface brings information into context.
Current work refines program definitions and staged evidence plans.
02
Invention foundation
Ideas documented. Evidence structured.
IEUM has built a double-digit portfolio of documented invention candidates, supported by structured internal technical dossiers and targeted public prior-art comparisons.
Internal prioritization and preliminary planning for professional review and a phased filing strategy have also been undertaken. With financing, qualified patent counsel can support a staged protection strategy for selected candidates.
The broader portfolio includes verification technology research such as NEXUS-ASSURE.
Investment and collaboration inquiries
From public purpose to selected evidence.
The public overview introduces program objectives, development direction, and our existing preparation. We welcome inquiries about investment, research collaboration, and early-stage support. Detailed technical review can follow a controlled process after a mutual NDA is fully executed and effective, within an agreed scope.
Contact Junho Jung →Founder & CTO · IEUM Bionics · Germany